Business

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21

HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that Kraig Higginson, ...

articleAspire Biopharma Holdings, Inc.May 8, 20252/company/aspire-biopharma-inc/news/aspire-biopharma-holdings-inc-present-120000433
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21

About this update from Aspire Biopharma Holdings, Inc.

[{"type":"text","content":"HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that Kraig Higginson, Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on May 21 at 2:30 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.zoom.us/webinar/register/WN_q62DwzilROyKt-kOh_GJDQ","length":562,"tagName":"p"},{"type":"text","content":"One-on-One Meetings","length":19,"tagName":"p"},{"type":"text","content":"Inspire will also host virtual one-on-ones with investors on Wednesday, May 21 and Thursday, May 22, 2025. To register for the presentation or one-on ones, visit https://sidoti.com/events.","length":188,"tagName":"p"},{"type":"text","content":"A replay of the presentation will be available on the investor relations section of Inspire's website at https://ir.aspirebiolabs.com/events/","length":145,"tagName":"p"},{"type":"text","content":"About Aspire Biopharma, Inc.","length":28,"tagName":"p"},{"type":"text","content":"Headquartered in Humacao, Puerto Rico, Aspire Biopharma has developed a disruptive technology through a Novel Soluble Formulation which addresses emergencies, drug efficacy, dosage management, and response time. For more information, please visit www.aspirebiolabs.com.","length":269,"tagName":"p"},{"type":"text","content":"Safe Harbor Statement","length":21,"tagName":"p"},{"type":"text","content":"Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar exp...

More updates from Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc.Aspire Biopharmaforward-looking statementsACCESS Newswire